Need all Congresses? Press Enter for expanded federal results.

HB 153

Kentucky House of Representatives bill in Session 26RS.

Status: in_committee. Latest action: January 14, 2026.

AN ACT relating to administrative regulations for medications for substance use disorder and declaring an emergency.

Bill ID KY-26RS-HB-153
Session 26RS
Status in_committee
Committee Health Services
House of Representatives in_committee 2026-01-14
Summary

Create a new section of KRS Chapter 13A to find 201 KAR 9:270 and 201 KAR 20:065 deficient and void; create new sections of KRS Chapters 311, 313, 314, and 315 to establish that the State Board of Medical Licensure, Board of Dentistry, Kentucky Board of Nursing, and Kentucky Board of Pharmacy shall not promulgate administrative regulations that restrict or limit the prescribing, dispensing, or administering of buprenorphine-mono-product, buprenorphine-combined-with-naloxone, or any other Schedule III, IV, or V medication approved by the United States Food and Drug Administration for the treatment of a substance use disorder; EMERGENCY.

Sponsor
Lisa Willner
Official Source Back to Bills
Actions Timeline
Date Event Detail
2026-01-07 Introduced Bill introduced
2026-01-14 Status in_committee
2026-01-14 Latest Action 01/14/26: to Health Services (H)
More Bills From This Sponsor
More Bills In This Topic
Related Topics
Same Topic Bills From Other States